Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
EBS — Emergent BioSolutions Inc.
NYSE
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 1, 2026
REVENUE
$156.1M +5.0%
NET MARGIN
4.4% +41.1 PTS
EPS
$0.13 +112.5%
FREE CASH FLOW
-$36.2M -149.1%

No summary has been written for this call yet.